sur M1 Kliniken AG (isin : DE000A0STSQ8)
M1 Kliniken AG: HAEMATO AG Considers Sale of Trading Segment
M1 Kliniken AG has announced that its majority-held subsidiary, HAEMATO AG, is evaluating a Conditional Binding Offer (CBO) for the sale of its trading segment. The segment in question is the fully owned HAEMATO PHARM GmbH. Both the Executive Board and Supervisory Board of HAEMATO AG are currently reviewing this proposal carefully.
The potential divestment of the trading segment aligns with M1 Kliniken AG’s strategic objective to concentrate efforts on its burgeoning beauty sector. This move could signify a major shift in focus, allowing the company to enhance growth in this area.
Further information from the company is anticipated as the review process progresses, ensuring stakeholders remain informed about any developments.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de M1 Kliniken AG